Podcast

Ethan Zohn: A Survivor in More Ways Than One

Author(s):

Jessica Skarzynski

On this week’s episode of the “CURE Talks Cancer” podcast, we spoke with “Survivor: Africa” winner Ethan Zohn on his journey with cancer and advocating for lymphoma awareness.

After experiencing what he described as “debilitatingly itchy skin” in 2009, former professional soccer player and “Survivor: Africa” winner Ethan Zohn went from winning the ultimate prize on the popular reality show to taking on a rare form of Hodgkin lymphoma not once, but twice. But thanks to a regimen of intense treatments and two stem cell transplants from his brother, Zohn was declared cancer-free in 2013 and went on to return to the 40th season of “Survivor” earlier this year in the Winners At War competition.

This week, we’re talking with Zohn about how his time on “Survivor” helped him take on cancer multiple times — and about how he never lets a crisis go to waste.

Related Videos
Dr. Sattva S. Neelapu is a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
Image of a woman with a brown hair tied into a bun.
Related Content
An image of a doctor taking notes.
January 24th 2025

Whitesnake Guitarist John Sykes Died of Cancer, Mike Peters Starting CAR-T

Alex Biese
From the deaths of John Sykes and former Planned Parenthood President Cecile Richards to an update from Mike Peters, here’s this week’s cancer news.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Illustration of blood cells.
January 21st 2025

Glucarpidase May Improve Renal Outcomes in Lymphoma, Leukemia

Ryan Scott
Patients with lymphoma or leukemia with methotrexate-induced acute kidney injury experienced improved renal outcomes following glucarpidase treatment.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
CAR-T Cell Therapy in Hematologic Malignancies
January 6th 2025

Understanding the Intricacies of CAR-T Cell Therapy and Care in Hematologic Malignancies

Ryan Scott
Dr. Sattva S. Neelapu discusses the intricacies of CAR T-cell therapy treatment and care for patients with hematologic malignancies.
Illustration of woman with brown curly hair.
January 2nd 2025

Survivor’s Guilt: Asking, ‘Why Me?’

Karen Cohn
Despite being declared cancer-free after initial treatment, I grapple with survivor's guilt, questioning why my lymphoma responded to therapy while others did not.